CMS glucometer cleaning guidelines require any Medicare- or Medicaid-participating facility that shares a blood glucose meter between patients to clean and disinfect the device after every use, following the meter manufacturer’s instructions and using an EPA-registered disinfectant proven effective against bloodborne pathogens. Skipping steps, rushing contact time, or sharing a meter that was never designed for multi-patient use can trigger an F-880 infection control citation, civil money penalties reaching $27,378 per instance, and in serious cases termination from the programs.
Who the Rules Apply To
The requirement reaches any facility participating in Medicare or Medicaid that uses shared glucometers on patients. The specific regulation depends on the setting. Nursing homes and skilled nursing facilities fall under 42 CFR § 483.80, which requires a written infection prevention and control program covering surveillance, reporting, standard precautions, and hand hygiene.1eCFR. 42 CFR 483.80 – Infection Control Hospitals are governed by 42 CFR § 482.42, which requires hospital-wide surveillance and prevention programs consistent with nationally recognized infection prevention guidelines.2eCFR. 42 CFR 482.42 – Condition of Participation: Infection Prevention and Control and Antibiotic Stewardship Programs Ambulatory surgery centers are covered by 42 CFR § 416.51.3eCFR. 42 CFR 416.51 – Conditions for Coverage: Infection Control All three demand written policies, adherence to accepted infection prevention standards, and active prevention of pathogen transmission through shared equipment.
Which Meters Can Be Shared at All
Not every glucometer is legally shareable. The FDA warns that over-the-counter blood glucose monitoring systems are intended for single-patient use and should not be shared.4U.S. Food and Drug Administration. Blood Glucose Monitoring Devices The CDC advises that if a facility must share meters, it should select a device designed for professional multi-patient use rather than a consumer model.5Centers for Disease Control and Prevention. Considerations for Blood Glucose Monitoring and Insulin Administration
The controlling rule is straightforward: if the manufacturer provides no instructions for cleaning and disinfecting the device between patients, the device cannot be shared. CMS states this plainly in its survey guidance.6Centers for Medicare & Medicaid Services. CMS Memorandum S&C 10-28-NH – Point of Care Devices and Infection Control in Nursing Homes A consumer-grade meter being passed among residents is a compliance failure on its face, regardless of how carefully staff try to wipe it down.
Cleaning and Disinfection: Two Steps, Not One
Cleaning and disinfection are distinct actions. Cleaning is the mechanical work of removing visible blood, soil, and organic debris from the exterior surfaces. Disinfection is the chemical step that kills residual pathogens. Disinfection without prior cleaning often fails, because organic material shields microorganisms from the chemical agent.
After each patient use, follow this sequence:
- Perform hand hygiene and put on clean gloves before handling the potentially contaminated device.
- Wipe all exterior surfaces (front, back, sides) with a detergent wipe to remove any visible blood or organic material. Avoid the test strip port and electronic connections.
- Apply the EPA-registered disinfectant approved by the meter manufacturer, coating all surfaces evenly.
- Keep the surface visibly wet for the full contact time printed on the disinfectant label. If it dries early, reapply.
- Let the device air dry completely. Do not towel it off or blow on it.
- Remove and discard gloves, then perform hand hygiene again.
- Store the dry meter in a designated clean location. Do not carry meters in pockets, and store single-patient meters in a way that prevents inadvertent use on other residents.7Centers for Medicare & Medicaid Services. State Operations Manual Appendix PP
Timing matters in real conditions. A 2024 CDC investigation in North Carolina documented Hepatitis B transmission between two residents tested with the same glucometer less than one minute apart, an interval that made proper disinfection physically impossible.8Centers for Disease Control and Prevention. Notes from the Field: Hepatitis B Virus Transmission Associated with Assisted Monitoring of Blood Glucose The contact time on the label is a minimum, not a suggestion.
Choosing a Compliant Disinfectant
The EPA maintains List S, a database of registered antimicrobial products effective against HIV, Hepatitis B, and Hepatitis C.9U.S. Environmental Protection Agency. EPA’s Registered Antimicrobial Products Effective Against Bloodborne Pathogens: Human Immunodeficiency Virus (HIV), Hepatitis B and Hepatitis C – List S Being on List S does not guarantee the product covers all three pathogens. Check the label to confirm it lists directions for use against HBV specifically, since Hepatitis B is the hardest to kill and has driven most glucometer-related outbreaks. Each pathogen on a given label may have its own required contact time.
Two common shortcuts are wrong. The CMS State Operations Manual notes that 70% ethanol solutions are not effective against viral bloodborne pathogens, and 10% bleach solutions can physically degrade the device.7Centers for Medicare & Medicaid Services. State Operations Manual Appendix PP Before purchasing any disinfectant, confirm with the glucometer manufacturer that the product is compatible with your device. Following EPA label directions, including contact time, is required by law for any registered antimicrobial product.9U.S. Environmental Protection Agency. EPA’s Registered Antimicrobial Products Effective Against Bloodborne Pathogens: Human Immunodeficiency Virus (HIV), Hepatitis B and Hepatitis C – List S
Fingerstick Devices Are Treated Differently
CMS separates two violations. A shared glucometer that was not properly cleaned is a deficiency that warrants corrective action. Reusing a fingerstick (lancing) device on more than one patient is classified as immediate jeopardy, the most serious deficiency category CMS uses. Appendix Q identifies using the same fingerstick device on more than one resident as a trigger for immediate jeopardy investigation.10Centers for Medicare & Medicaid Services. Appendix Q – Core Guidelines for Determining Immediate Jeopardy
Immediate jeopardy carries the most severe sanctions available, including mandatory corrective action plans on accelerated timelines and the highest penalty tier. The CDC recommends single-use, auto-disabling fingerstick devices in any setting performing assisted blood glucose monitoring, which removes the possibility of accidental reuse. Even if a lancing device’s packaging suggests multi-patient use, CMS guidance built on CDC and FDA standards prohibits it.6Centers for Medicare & Medicaid Services. CMS Memorandum S&C 10-28-NH – Point of Care Devices and Infection Control in Nursing Homes
Written Policies, Training, and Documentation
Facilities must maintain written infection prevention policies specific to the equipment they use. A compliant glucometer policy identifies the exact meter model in use, the approved disinfectant product (confirmed compatible by the manufacturer), the required contact time for that product, and the step-by-step procedure staff follow between patients.1eCFR. 42 CFR 483.80 – Infection Control
Every staff member who handles a glucometer needs initial training before performing patient testing, and competency should be verified through direct observation rather than a signed acknowledgment. Surveyors routinely ask staff to demonstrate the process, and a staffer who cannot perform it correctly becomes evidence of a systemic training failure. Retrain and reassess when the facility changes meter models, switches disinfectants, or when CMS updates its guidance. Keep dated records of training sessions, competency checks, and protocol changes; those logs are the primary evidence of compliance during a survey.
CLIA Certificate of Waiver
Blood glucose testing with FDA-cleared home-use devices is classified as a CLIA-waived test under 42 CFR § 493.15.11eCFR. 42 CFR 493.15 – Laboratories Performing Waived Tests Waived does not mean unregulated. Any facility that performs even one glucose test on a patient for clinical purposes must hold a valid Certificate of Waiver from CMS, applied for on Form CMS-116 through the state agency where the laboratory is located.12Centers for Medicare & Medicaid Services. How to Obtain a CLIA Certificate Certificate holders must follow the manufacturer’s instructions for the test, including the instructions for cleaning and disinfection. Testing without a valid certificate, or ignoring the manufacturer’s IFU, creates a separate layer of regulatory exposure on top of any infection control citations.
Citations and Penalties
Surveyors cite glucometer cleaning failures in long-term care under tag F-880, tied to 42 CFR § 483.80.13U.S. Department of Health and Human Services. Sun West Choice Healthcare and Rehabilitation, DAB CR6254 The surveyor sets scope and severity using Appendix PP. Failing to clean and disinfect a shared glucometer is a deficiency warranting corrective action; it does not automatically rise to immediate jeopardy. Reusing a fingerstick device does.6Centers for Medicare & Medicaid Services. CMS Memorandum S&C 10-28-NH – Point of Care Devices and Infection Control in Nursing Homes
For 2026, CMS civil money penalties for nursing facility deficiencies are:14Federal Register. Annual Civil Monetary Penalties Inflation Adjustment
- Lower-range per-day penalties: $136 to $8,211 per day of noncompliance.
- Upper-range per-day penalties: $8,351 to $27,378 per day of noncompliance.
- Per-instance penalties: $2,739 to $27,378 per instance.
Per-day penalties accumulate until the deficiency is corrected and verified through an on-site revisit. Beyond dollars, serious or repeated infection control failures can lead to denial of payment for new admissions, mandatory state monitoring, or termination from the Medicare and Medicaid programs.